In contrast, MERTK kinase seems to be more abundantly expressed in acute lymphoblastic leukaemias, therefore a selective MERTK inhibition could be an interesting therapeutic strategy in this context [164,165,166,167]. Here, MERTK is linked to acute lymphoblastic leukemia.